Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Home Print this page Email this page Small font size Default font size Increase font size Users Online: 868
Year : 2016  |  Volume : 39  |  Issue : 3  |  Page : 138-145

Validation of intensity-modulated radiotherapy commissioning as per recommendations in test plans of the American Association of Physicists in Medicine task group 119 report

1 Department of Applied Physics, Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India
2 Department of Radiation Oncology, Dr. B. L. Kapur Memorial Hospital, New Delhi, India
3 Department of Radiation Oncology, RGCI Hospital, New Delhi, India
4 Department of Physics, MMH College, Ghaziabad, Uttar Pradesh, India

Correspondence Address:
Sandeep Kaushik
Department of Applied Physics, Guru Jambheshwar University of Science and Technology, Hisar - 125 001, Haryana
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0972-0464.194960

Rights and Permissions

In the present study, intensity-modulated radiotherapy (IMRT) commissioning has been validated as per the task group report 119 (TG119) of the American Association of Physicists in Medicine (AAPM). The plans have been done on structure and computed tomography scanned data set downloaded from the AAPM website. IMRT test planning has been performed to achieve conformed dose and dose distribution similar to that described in the AAPM TG119 report. Point dose measurements with ionization chamber have been taken on solid water phantom at a depth of 7.5 cm. Measurements were performed in two locations, i.e. at target volume and low dose avoidance structure, with planned machine parameters. Gamma evaluation of dose distribution produced by each field has also been done individually using electronic portal imaging device (EPID). Overall mean deviation obtained for ion chamber measurement was −0.012 (standard deviation [SD]: 0.015) with confidence limit (CL) 0.043 and −0.0012 (SD: 0.009) with CL 0.020 in high-dose region and low-dose region, respectively. Overall mean gamma passing in portal dosimetry calculated specifically for EPID has been observed 99.5% with SD 0.33 and CL 1.13. The results obtained for ion chamber dosimetry and portal dosimetry are much better than those reported in the AAPM TG119 report. Better results in gamma evaluation further reduced CL for EPID users.

Print this article     Email this article
Next article
Previous article
Table of Contents
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Citation Manager
Access Statistics
Reader Comments
Email Alert *
Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded170    
    Comments [Add]    

Recommend this journal